The MPTP model: versatile contributions to the treatment of idiopathic Parkinson's disease
Identifieur interne : 002732 ( Main/Exploration ); précédent : 002731; suivant : 002733The MPTP model: versatile contributions to the treatment of idiopathic Parkinson's disease
Auteurs : B. R. Bloem ; I. Irwin ; O. J. S. Buruma ; J. Haan ; R. A. C. Roos ; J. W. Tetrud ; J. W. LangstonSource :
- Journal of the Neurological Sciences [ 0022-510X ] ; 1990.
Abstract
In human and subhuman primates, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) produces irreversible clinical, biochemical and neuropathological alterations highly reminiscent of those observed in Parkinson's disease. The MPTP model has provided the best available tool to date for the assessment of efficacy and side-effects of symptomatic treatments of Parkinson's disease. In addition, the mechanism of action of MPTP has offered a basis for the development of novel therapeutic strategies aimed at the prevention of Parkinson's disease.
Url:
DOI: 10.1016/0022-510X(90)90225-C
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>The MPTP model: versatile contributions to the treatment of idiopathic Parkinson's disease</title><author><name sortKey="Bloem, B R" sort="Bloem, B R" uniqKey="Bloem B" first="B. R." last="Bloem">B. R. Bloem</name></author><author><name sortKey="Irwin, I" sort="Irwin, I" uniqKey="Irwin I" first="I." last="Irwin">I. Irwin</name></author><author><name sortKey="Buruma, O J S" sort="Buruma, O J S" uniqKey="Buruma O" first="O. J. S." last="Buruma">O. J. S. Buruma</name></author><author><name sortKey="Haan, J" sort="Haan, J" uniqKey="Haan J" first="J." last="Haan">J. Haan</name></author><author><name sortKey="Roos, R A C" sort="Roos, R A C" uniqKey="Roos R" first="R. A. C." last="Roos">R. A. C. Roos</name></author><author><name sortKey="Tetrud, J W" sort="Tetrud, J W" uniqKey="Tetrud J" first="J. W." last="Tetrud">J. W. Tetrud</name></author><author><name sortKey="Langston, J W" sort="Langston, J W" uniqKey="Langston J" first="J. W." last="Langston">J. W. Langston</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:141E3706E6A043BC990A51F2F1C1D1CDEC36BE16</idno><date when="1990" year="1990">1990</date><idno type="doi">10.1016/0022-510X(90)90225-C</idno><idno type="url">https://api.istex.fr/document/141E3706E6A043BC990A51F2F1C1D1CDEC36BE16/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">003078</idno><idno type="wicri:Area/Main/Curation">002C83</idno><idno type="wicri:Area/Main/Exploration">002732</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">The MPTP model: versatile contributions to the treatment of idiopathic Parkinson's disease</title><author><name sortKey="Bloem, B R" sort="Bloem, B R" uniqKey="Bloem B" first="B. R." last="Bloem">B. R. Bloem</name><affiliation><wicri:noCountry code="subField">Leiden The Netherlands</wicri:noCountry></affiliation></author><author><name sortKey="Irwin, I" sort="Irwin, I" uniqKey="Irwin I" first="I." last="Irwin">I. Irwin</name><affiliation><wicri:noCountry code="subField">CA U.S.A.</wicri:noCountry></affiliation></author><author><name sortKey="Buruma, O J S" sort="Buruma, O J S" uniqKey="Buruma O" first="O. J. S." last="Buruma">O. J. S. Buruma</name><affiliation><wicri:noCountry code="subField">Leiden The Netherlands</wicri:noCountry></affiliation></author><author><name sortKey="Haan, J" sort="Haan, J" uniqKey="Haan J" first="J." last="Haan">J. Haan</name><affiliation><wicri:noCountry code="subField">Leiden The Netherlands</wicri:noCountry></affiliation></author><author><name sortKey="Roos, R A C" sort="Roos, R A C" uniqKey="Roos R" first="R. A. C." last="Roos">R. A. C. Roos</name><affiliation><wicri:noCountry code="subField">Leiden The Netherlands</wicri:noCountry></affiliation></author><author><name sortKey="Tetrud, J W" sort="Tetrud, J W" uniqKey="Tetrud J" first="J. W." last="Tetrud">J. W. Tetrud</name><affiliation><wicri:noCountry code="subField">CA U.S.A.</wicri:noCountry></affiliation></author><author><name sortKey="Langston, J W" sort="Langston, J W" uniqKey="Langston J" first="J. W." last="Langston">J. W. Langston</name><affiliation><wicri:noCountry code="subField">CA U.S.A.</wicri:noCountry></affiliation></author></analytic><monogr></monogr><series><title level="j">Journal of the Neurological Sciences</title><title level="j" type="abbrev">JNS</title><idno type="ISSN">0022-510X</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1990">1990</date><biblScope unit="volume">97</biblScope><biblScope unit="issue">2–3</biblScope><biblScope unit="page" from="273">273</biblScope><biblScope unit="page" to="293">293</biblScope></imprint><idno type="ISSN">0022-510X</idno></series><idno type="istex">141E3706E6A043BC990A51F2F1C1D1CDEC36BE16</idno><idno type="DOI">10.1016/0022-510X(90)90225-C</idno><idno type="PII">0022-510X(90)90225-C</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0022-510X</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In human and subhuman primates, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) produces irreversible clinical, biochemical and neuropathological alterations highly reminiscent of those observed in Parkinson's disease. The MPTP model has provided the best available tool to date for the assessment of efficacy and side-effects of symptomatic treatments of Parkinson's disease. In addition, the mechanism of action of MPTP has offered a basis for the development of novel therapeutic strategies aimed at the prevention of Parkinson's disease.</div></front></TEI><affiliations><list></list><tree><noCountry><name sortKey="Bloem, B R" sort="Bloem, B R" uniqKey="Bloem B" first="B. R." last="Bloem">B. R. Bloem</name><name sortKey="Buruma, O J S" sort="Buruma, O J S" uniqKey="Buruma O" first="O. J. S." last="Buruma">O. J. S. Buruma</name><name sortKey="Haan, J" sort="Haan, J" uniqKey="Haan J" first="J." last="Haan">J. Haan</name><name sortKey="Irwin, I" sort="Irwin, I" uniqKey="Irwin I" first="I." last="Irwin">I. Irwin</name><name sortKey="Langston, J W" sort="Langston, J W" uniqKey="Langston J" first="J. W." last="Langston">J. W. Langston</name><name sortKey="Roos, R A C" sort="Roos, R A C" uniqKey="Roos R" first="R. A. C." last="Roos">R. A. C. Roos</name><name sortKey="Tetrud, J W" sort="Tetrud, J W" uniqKey="Tetrud J" first="J. W." last="Tetrud">J. W. Tetrud</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002732 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002732 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:141E3706E6A043BC990A51F2F1C1D1CDEC36BE16
|texte= The MPTP model: versatile contributions to the treatment of idiopathic Parkinson's disease
}}
| This area was generated with Dilib version V0.6.23. |  |